These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34502472)

  • 1. Protective Role of a Donepezil-Huprine Hybrid against the β-Amyloid (1-42) Effect on Human Erythrocytes.
    Zambrano P; Suwalsky M; Jemiola-Rzeminska M; Gallardo-Nelson MJ; Strzalka K; Muñoz-Torrero D
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rhein-huprine hybrid protects erythrocyte membrane integrity against Alzheimer's disease related Aβ(1-42) peptide.
    Zambrano P; Jemiola-Rzeminska M; Muñoz-Torrero D; Suwalsky M; Strzalka K
    Biophys Chem; 2023 Sep; 300():107061. PubMed ID: 37307659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acetylcholinesterase (AChE) inhibitor and anti-Alzheimer drug donepezil interacts with human erythrocytes.
    Zambrano P; Suwalsky M; Jemiola-Rzeminska M; Strzalka K; Sepúlveda B; Gallardo MJ; Aguilar LF
    Biochim Biophys Acta Biomembr; 2019 Jun; 1861(6):1078-1085. PubMed ID: 30904408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vitro study on the interaction of the anti-Alzheimer drug rivastigmine with human erythrocytes.
    Zambrano P; Suwalsky M; Jemiola-Rzeminska M; Strzalka K; Aguilar LF
    Chem Biol Interact; 2020 Mar; 319():109019. PubMed ID: 32092302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multigram synthesis and in vivo efficacy studies of a novel multitarget anti-Alzheimer's compound.
    Sola I; Viayna E; Gómez T; Galdeano C; Cassina M; Camps P; Romeo M; Diomede L; Salmona M; Franco P; Schaeffer M; Colantuono D; Robin D; Brunner D; Taub N; Hutter-Paier B; Muñoz-Torrero D
    Molecules; 2015 Mar; 20(3):4492-515. PubMed ID: 25764491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
    Galdeano C; Viayna E; Sola I; Formosa X; Camps P; Badia A; Clos MV; Relat J; Ratia M; Bartolini M; Mancini F; Andrisano V; Salmona M; Minguillón C; González-Muñoz GC; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Muñoz-Torrero D
    J Med Chem; 2012 Jan; 55(2):661-9. PubMed ID: 22185619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
    Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
    Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of the anti-Alzheimer drug memantine on the human erythrocyte membrane and molecular models.
    Zambrano P; Suwalsky M; Villena F; Jemiola-Rzeminska M; Strzalka K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):528-533. PubMed ID: 27998775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro study on the antioxidant capacity of usnic acid on human erythrocytes and molecular models of its membrane.
    Suwalsky M; Jemiola-Rzeminska M; Astudillo C; Gallardo MJ; Staforelli JP; Villena F; Strzalka K
    Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2829-38. PubMed ID: 26299817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory potency of 4- substituted sampangine derivatives toward Cu
    Su C; Chen Y; Chen K; Li W; Tang H
    Neurochem Int; 2020 Oct; 139():104794. PubMed ID: 32650027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
    Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
    ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane.
    Petit K; Suwalsky M; Colina JR; Aguilar LF; Jemiola-Rzeminska M; Strzalka K
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):17-25. PubMed ID: 30336115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological Effects Induced In Vitro by Propranolol on Human Erythrocytes.
    Suwalsky M; Zambrano P; Villena F; Manrique-Moreno M; Gallardo MJ; Jemiola-Rzeminska M; Strzalka K; Edwards AM; Mennickent S; Dukes N
    J Membr Biol; 2015 Aug; 248(4):683-93. PubMed ID: 25724773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro protective effects of resveratrol against oxidative damage in human erythrocytes.
    Suwalsky M; F Villena ; Gallardo MJ
    Biochim Biophys Acta; 2015 Jan; 1848(1 Pt A):76-82. PubMed ID: 25268679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
    Camps P; Cusack B; Mallender WD; El Achab RE; Morral J; Muñoz-Torrero D; Rosenberry TL
    Mol Pharmacol; 2000 Feb; 57(2):409-17. PubMed ID: 10648652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylsalicylic acid (aspirin) and salicylic acid interaction with the human erythrocyte membrane bilayer induce in vitro changes in the morphology of erythrocytes.
    Suwalsky M; Belmar J; Villena F; Gallardo MJ; Jemiola-Rzeminska M; Strzalka K
    Arch Biochem Biophys; 2013 Nov; 539(1):9-19. PubMed ID: 24055635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of phenylpropanolamine (PPA) on in vitro human erythrocyte membranes and molecular models.
    Suwalsky M; Zambrano P; Mennickent S; Villena F; Sotomayor CP; Aguilar LF; Bolognin S
    Biochem Biophys Res Commun; 2011 Mar; 406(3):320-5. PubMed ID: 21320467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
    Pérez-Areales FJ; Di Pietro O; Espargaró A; Vallverdú-Queralt A; Galdeano C; Ragusa IM; Viayna E; Guillou C; Clos MV; Pérez B; Sabaté R; Lamuela-Raventós RM; Luque FJ; Muñoz-Torrero D
    Bioorg Med Chem; 2014 Oct; 22(19):5298-307. PubMed ID: 25156301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.
    Bokvist M; Lindström F; Watts A; Gröbner G
    J Mol Biol; 2004 Jan; 335(4):1039-49. PubMed ID: 14698298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.